Optimizing Oncology Sales and Marketing with Lab Data
Rather than prescribing every cancer patient the same treatment regimen, oncologists and other...
5 ways to optimize sales force efficiency with lab data and AI
As a life sciences brand manager, you are likely always looking to refine your sales and marketing...
Diabetes and RA: Further Explanations for Comorbidity
Why, how, and what might be next? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener
Comorbidity Between Diabetes and RA
How is comorbidity affected by a double positive? By Jason Bhan, MD, Fernando Schwartz, PhD, and...
Diabetes and Rheumatoid Arthritis: A Missing Link?
Is there an unidentified link between diabetes and RA?
5 Ways Life Science Brands Are Putting AI to Work
Healthcare AI delivers actionable insights to pharma companies by recognizing key trends and...
What’s Next in Pancreatic Cancer Screening
What Prognos Found and Where We’ll Take It By Jason Bhan, MD, Fernando Schwartz, Brian Saindon, &...
Further Analysis of Pancreatic Cancer Test Results
Opening the Window of Opportunity for Pancreatic Cancer Screening By Jason Bhan, MD, Carol Smyth,...
Pancreatic Cancer Screening: Initial Results
Prognos Results: Part 1 By Carol Smyth, MD & Brian Saindon
Our Pancreatic Cancer Analysis: How We Did It
The Prognos Study Method By Carol Smyth, MD & Brian Saindon